Are you a medical and scientific expert focused on finding new treatments for patients living with cardiovascular diseases? Would you like to join the organization that has an unwavering dedication to improving the lives of patients living with serious chronic diseases? If so, then this opportunity could be for you!
The Position
We are looking for an International Medical Vice President (IMVP) who will provide an expert guidance on all aspects of clinical and scientific drug development withing Cardiovascular area. This is a central role in securing Novo Nordisk position as one of the market leaders in Cardiovascular space and enabling further advancements of our portfolio of cardiovascular treatments. The role offers an exciting opportunity to join an industry-leading team of approximately 50 ambitious and highly dedicated medical and clinical experts that are focused on enabling drug development for Cardiovascular, Kidney & Alzheimer's Diseases.
The position is based in Søborg, Greater Copenhagen area, Denmark.
Key Responsibilities
Reporting to the Vice President for Medical & Science, Cardiovascular, Kidney & Alzheimer's Disease the IMVP, Cardiovascular Disease is a critical role in Clinical Development organization that collaborates with a large number of stakeholders in a complex matrix setting. As a key opinion leader on cardiovascular diseases, the IMVP represents Novo Nordisk at industry events, government working groups and in interactions with authorities.
The key responsibilities of International Medical Vice President include:
Qualifications
We are looking for an experienced pharma industry medical and scientific leader with the following qualifications and skills:
This is an ideal position for a forward thinking and innovative cardiovascular expert that would like to use their knowledge and experience to make the difference for people living with cardiovascular diseases across the world and enjoys working with likeminded colleagues, driven by the common goal.
About the Department
Cardiovascular, Kidney & Alzheimer's Disease drives Novo Nordisk’s expanding portfolio within serious chronic diseases such as cardiovascular diseases, chronic kidney disease and Alzheimer’s disease and also executing large outcomes trials. The department is part of Novo Nordisk’s Clinical Drug Development area.
Working at Novo Nordisk
At Novo Nordisk, we don’t wait for change. We drive it. We’re a dynamic company in an even more dynamic industry, and we know that what got us to where we are today is not necessarily what will make us successful in the future. We embrace the spirit of experimentation, striving for excellence without fixating on perfection. We never shy away from opportunities to develop, we seize them. From research and development, through to manufacturing, marketing, and sales – we’re all working to move the needle on patient care.
Deadline
We look forward to receiving your application latest by 3d of March 2025.
We commit to an inclusive recruitment process and equality of opportunity for all our job applicants.
At Novo Nordisk we recognize that it is no longer good enough to aspire to be the best company in the world. We need to aspire to be the best company for the world and we know that this is only possible with talented employees with diverse perspectives, backgrounds and cultures. We are therefore committed to creating an inclusive culture that celebrates the diversity of our employees, the patients we serve and communities we operate in. Together, we’re life changing.
Husk at skrive i din ansøgning, at du så jobbet hos Ofir